Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 7/20 | 0.59 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.56 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.56 |
| ▸ | PTGES | O14684 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CES1 | P23141 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6427641 | 0.85 | CYP3A4 (0.61) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 | |
| SCHEMBL7648958 | 0.85 | CYP3A4 (0.61) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 | |
| SCHEMBL28315467 | 0.82 | ALOX5 (0.57) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 | |
| Methyl 3,5-Dinitrobenzoate SCHEMBL418416 | 0.82 | SMN1; SMN2 (0.60) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 | |
| SCHEMBL828959 | 0.81 | TSHR (0.69) | CYP3A4SMN1; SMN2ALOX5KDM4ECES1 | |
| SCHEMBL27709137 | 0.80 | ALOX5 (0.75) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 | |
| SCHEMBL248294 | 0.79 | TSHR (0.64) | PTPN2PTPN1GAAKDM4ETDP1 | |
| SCHEMBL15751973 | 0.79 | ALOX5 (0.54) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 | |
| SCHEMBL13384984 | 0.79 | ALOX5 (0.84) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 | |
| Nitromide SCHEMBL193674 | 0.78 | CYP3A4 (1.00) | CYP3A4SMN1; SMN2ALOX5PTPN2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954617-A | Method for preparing 4-methoxyphenol from anisole | 河南大学 | 2025-05-09 | — | — | CN | claimed |
| US-20240292726-A1 | METHOD OF MANUFACTURING QLED DEVICE, QLED DEVICE, AND DISPLAY DEVICE | TCL TECHNOLOGY GROUP CORPORATION (CN) | 2024-08-29 | — | — | US | claimed |
| CN-118290820-A | Preparation method and application of solid glass beads | 万华化学（宁波）有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-117903064-A | 2-Sulfonyl pyrimidine-4-carboxamide compound I and synthetic method thereof | 西北师范大学 | 2024-04-19 | — | — | CN | claimed |
| CN-117903065-A | Synthesis method of 2-sulfonyl pyrimidine-4-carboxamide compound II | 西北师范大学 | 2024-04-19 | — | — | CN | claimed |
| CN-113816920-B | Synthesis method of chlorzoxazone | 鲁南制药集团股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-115734631-A | Preparation method of QLED device, QLED device and display device | TCL科技集团股份有限公司 | 2023-03-03 | — | — | CN | claimed |
| WO-2023025297-A1 | METHOD FOR PREPARING QLED DEVICE, QLED DEVICE AND DISPLAY DEVICE | TCL科技集团股份有限公司 | 2023-03-02 | — | — | WO | claimed |
| CN-113122212-B | Preparation method and application of profile control agent | 中国石油天然气股份有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-113816920-A | Synthetic method of chlorzoxazone | 鲁南制药集团股份有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-20060223743-A1 | Metabolites of cyclosporin analogs | ISOTECHNIKA INC. (CA) | 2006-10-05 | — | — | US | claimed |
| WO-2006063470-A1 | METABOLITES OF CYCLOSPORIN ANALOGS | ISOTECHNIKA INC. (CA) | 2006-06-22 | — | — | WO | claimed |
| EP-1387822-B1 | 2-[4-(2,2,-DIHALOCYCLOPROPYL)PHENOXY]-ALKANOIC ACIDS AND ESTERS THEREOF PRODUCTION PROCESS | LABORATORIO CHIMICO INT SPA (IT) | 2005-06-15 | — | — | EP | claimed |
| US-20050070715-A1 | Methods for synthesis of acyloxyalkyl compounds | ARBOR PHARMACEUTICALS, LLC | 2005-03-31 | — | — | US | claimed |
| WO-2005010011-A2 | METHODS OF SYNTHESIS OF ACYLOXYALKYL COMPOUNDS | XENOPORT, INC. (US) | 2005-02-03 | — | — | WO | claimed |
| EP-1387822-A1 | 2-[4-(2,2,-DIHALOCYCLOPROPYL)PHENOXY]-ALKANOIC ACIDS AND ESTERS THEREOF PRODUCTION PROCESS | LABORATORIO CHIMICO INTERNAZIONALE S.p.A. (IT) | 2004-02-11 | — | — | EP | claimed |
| WO-2002090307-A1 | 2-[4-(2, 2-DIHALOCYCLOPROPYL)PHENOXY]-ALKANOIC ACIDS AND ESTERS THEREOF PRODUCTION PROCESS | LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) | 2002-11-14 | — | — | WO | claimed |
| EP-0600317-B1 | Process for the preparation of halogenated benzoic acids | HOECHST AG (DE) | 1997-03-12 | — | — | EP | claimed |
| US-5481032-A | Process for the preparation of halogenated benzoic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-01-02 | — | — | US | claimed |
| EP-0600317-A1 | Process for the preparation of halogenated benzoic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223743-A1 | Metabolites of cyclosporin analogs | CYP2A7, CYP3A7, CYP3A43 | CYP3A4 11/4885SMN1; SMN2 4251/4885ALOX5 594/4885 |
| US-20050070715-A1 | Methods for synthesis of acyloxyalkyl compounds | AADAC, CYP2D6, CYP3A7 | CYP3A4 6/4885SMN1; SMN2 3880/4885ALOX5 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.